Services

Manufacturing Quality Remediation​

When quality failures jeopardize supply, we lead large-scale remediation programs that generate defensible evidence for health authorities while restoring operations and embedding a culture of sustainable quality. Our programs span audit triage, prioritized workstreams, CAPA execution, validation updates, and workforce capability building.​​

Case Studies

Full-site quality remediation for multi-product API plant

 

Execution of a comprehensive remediation program that restored compliant production and institutionalized new quality behaviors.​

Insights

Challenge: A long-running multi-product API site, after a new GM’s review, halted production due to systemic quality issues across processes and systems.​

Approach: We led third-party audits and grouped thousands of findings into 26 prioritized workstreams(CAPA, deviations, CSV, cleaning, maintenance, analytical methods, lab management, etc.). For each workstream, we deployed internal leads paired with external SMEs, established remediation plans and evidence-archiving protocols, and provided PMO and specialist support where needed.​

Impact: Within ~18–24 months, the program closed all but one finding, restored production with sustainable controls, and shifted site culture toward quality (some workforce changes and training were required).​

Focused Remediation to Enable Tech Transfer​

 

Stabilization of a product family for tech transfer by closing critical deviations, strengthening release controls, and preparing regulator-defensible evidence.​

Insights

Challenge: A product family experienced repeated batch holds due to deviations, which blocked planned tech transfers to secondary manufacturing sites and threatened continuity of supply for key markets.​

Approach: e performed rapid root-cause investigations to identify systemic contributors to deviations, implemented immediate containment measures to allow limited releases, and designed prioritized CAPA packages focused on the highest-impact failure modes. We standardized deviation investigation templates, accelerated analytical method re-qualification where needed, and documented closure packages in regulator-friendly formats. We coordinated with tech-transfer teams to integrate improved control descriptions and acceptance criteria into the transfer dossiers.​

Impact: The backlog of held batches was cleared, release controls were strengthened so batches could be released with defensible evidence, and the tech-transfer packages were validated—enabling the planned transfers without regulatory holds and restoring the client’s ability to scale supply.​